SG Americas Securities LLC Acquires 80,534 Shares of Encompass Health Corporation $EHC

SG Americas Securities LLC lifted its holdings in Encompass Health Corporation (NYSE:EHC) by 1,070.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 88,054 shares of the company’s stock after buying an additional 80,534 shares during the quarter. SG Americas Securities LLC owned about 0.09% of Encompass Health worth $9,346,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Alliancebernstein L.P. increased its position in Encompass Health by 23.4% in the 3rd quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock valued at $319,567,000 after acquiring an additional 476,564 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Encompass Health by 0.5% during the third quarter. Dimensional Fund Advisors LP now owns 1,616,178 shares of the company’s stock worth $205,279,000 after purchasing an additional 7,349 shares in the last quarter. Raymond James Financial Inc. grew its stake in shares of Encompass Health by 34.8% during the third quarter. Raymond James Financial Inc. now owns 1,541,336 shares of the company’s stock valued at $195,780,000 after purchasing an additional 397,694 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Encompass Health by 5.3% during the third quarter. JPMorgan Chase & Co. now owns 1,410,335 shares of the company’s stock valued at $179,141,000 after purchasing an additional 70,387 shares during the last quarter. Finally, Millennium Management LLC increased its holdings in shares of Encompass Health by 140.0% in the third quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock valued at $155,430,000 after purchasing an additional 713,738 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Performance

Encompass Health stock opened at $97.73 on Monday. The company has a market cap of $9.72 billion, a PE ratio of 17.64, a PEG ratio of 1.87 and a beta of 0.70. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99. The company’s 50-day moving average is $102.57 and its two-hundred day moving average is $111.11.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The business had revenue of $3.09 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same period in the previous year, the firm posted $1.17 earnings per share. Encompass Health’s revenue for the quarter was up 9.9% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Equities analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be given a dividend of $0.19 per share. The ex-dividend date is Wednesday, April 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.8%. Encompass Health’s payout ratio is presently 13.72%.

Wall Street Analysts Forecast Growth

EHC has been the topic of several research reports. Barclays upped their price objective on Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a report on Friday, February 6th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $143.29.

Insiders Place Their Bets

In related news, CEO Mark J. Tarr sold 150,000 shares of the company’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total value of $16,746,000.00. Following the completion of the sale, the chief executive officer owned 377,070 shares in the company, valued at approximately $42,096,094.80. This represents a 28.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Treasurer Edmund Fay sold 11,937 shares of the stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the transaction, the treasurer directly owned 89,325 shares in the company, valued at $9,557,775. The trade was a 11.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 2.10% of the company’s stock.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.